Valuation: IRADIMED CORPORATION

Market Cap 1.1B 962M 909M 828M 1.55B 105B 1.56B 10.88B 4.21B 53.7B 4.12B 4.03B 173B P/E 2026 *
44.3x
P/E 2027 * 38.1x
Enterprise Value 1.1B 962M 909M 828M 1.55B 105B 1.56B 10.88B 4.21B 53.7B 4.12B 4.03B 173B EV / Sales 2026 *
11.9x
EV / Sales 2027 * 10.5x
Free-Float
64.83%
Yield 2026 *
-
Yield 2027 * -
1 day+0.66%
1 week+4.43%
Current month-0.72%
1 month-1.95%
3 months-8.73%
6 months-13.15%
Current year-11.84%
1 week 81.51
Extreme 81.51
87.9
1 month 81.4
Extreme 81.405
88.4
Current year 76.95
Extreme 76.95
107.9
1 year 67.84
Extreme 67.8421
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
03/09/26 Sell

Director

-1,419 0.0111%
04/06/26 Sell

Director

-3,000 0.0235%
01/06/26 Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+0.66%+4.43%+22.04%+97.92% 1.1B
+0.21%+1.40%-29.04%-1.20% 12.47B
-7.14%-2.36%+9.78%+10.44% 4.16B
-2.48%+1.37%-43.34%-61.00% 1.21B
-0.57%+3.04%-40.83%-42.55% 1.09B
-1.58%+1.70%-34.49% - 1.03B
-3.18%-0.52% - - 996M
-2.64%-4.46%+29.60%+97.40% 494M
+7.78%-0.75%+45.20% - 333M
-0.18%+3.07%-69.86%+362.43% 234M
Average -0.91%+0.69%-12.33%+66.21% 2.31B
Weighted average by Cap. -1.45%+0.73%-18.84%+7.14%

Financials

2026 *2027 *
Net sales 92.07M 80.79M 76.3M 69.53M 130M 8.82B 131M 913M 354M 4.51B 346M 338M 14.49B 104M 91.35M 86.27M 78.62M 147M 9.98B 148M 1.03B 400M 5.1B 391M 382M 16.38B
Net income 24.9M 21.85M 20.64M 18.81M 35.2M 2.39B 35.46M 247M 95.65M 1.22B 93.49M 91.47M 3.92B 29.03M 25.48M 24.06M 21.93M 41.05M 2.78B 41.34M 288M 112M 1.42B 109M 107M 4.57B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
25/09/26 $85.76 +0.66% 146,428
24/09/26 $85.20 -1.33% 123,026
23/09/26 $86.35 -0.18% 164,107
22/09/26 $86.51 +4.91% 176,507
21/09/26 $82.46 +0.41% 120,118
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
85.76USD
Average target price
118.00USD
Spread / Average Target
+37.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock